Tag: transfection technologies market share

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Transfection Technologies Market Forecast: Value Set To Climb From $1.42 Billion To $1.98 Billion

The transfection technologies market has experienced robust expansion in recent years. Projections indicate it will expand from $1.31 billion in 2025 to $1.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion can be linked to several factors, including the surge in molecular biology research, progress in gene expression studies, the increasing demand for protein production, augmented funding for genomics research, and its initial uptake in academic settings.

The transfection technologies market size is anticipated to experience substantial growth over the coming years. This market is projected to reach $1.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. Key drivers for this expansion during the forecast period include the increasing adoption of cell and gene therapies, expanding RNA therapeutics pipelines, growing investments in life sciences research, the need for effective transfection reagents, and the broader development of personalized medicine. Prominent trends expected in the same period involve a heightened demand for gene editing research tools, an increase in RNA-based therapeutics development, wider application in cell and gene therapy, an uptick in academic and biomedical research, and advancements in non-viral transfection methods.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=32963996&type=smp&name=Transfection%20Technologies%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Transfection Technologies Market Growth Backed By Core Demand Fundamentals

The increasing prevalence of gene therapy is anticipated to boost the growth of the transfection technologies market moving forward. Gene therapy is a medical approach designed to manage or prevent diseases through genetic modification, which involves inserting, repairing, or replacing faulty genes. This growth in gene therapy is propelled by advancements in genetic research, improved delivery techniques, and its capability to address genetic conditions that were previously untreatable. Transfection technologies are essential for gene therapy, as they enable the accurate, safe, and effective transfer of genetic material into cells. These technologies facilitate both temporary and permanent alterations to the genome, which are critical for treating genetic diseases and cancers. For instance, in December 2024, as per the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) granted approval to six gene therapy products in 2023, an increase from five approvals in 2022. Thus, the expansion of gene therapy is fueling the development of the transfection technologies market.

Transfection Technologies Market Segmentation And Category Overview

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Transfection Technologies Market Growth Trends Reshaping The Competitive Landscape

Major companies in the transfection technologies market are concentrating on developing sophisticated technology, such as mechanoporation transfection systems, to facilitate more intricate and tailored applications in research and therapeutics. These mechanoporation transfection systems utilize mechanical forces to create temporary openings in cell membranes, allowing genetic material to enter cells. This method is efficient and minimally invasive, promoting better cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system includes a benchtop unit and the CellPore Transfection Kit 300, which is supplied with a specialized reagent kit and single-use delivery cartridges. By employing controlled, rapid deformation in microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These attributes are crucial for advancing research and the development of cutting-edge cell and gene therapies.

Transfection Technologies Market Competitive Analysis Of Leading Industry Participants

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

View The Full Transfection Technologies Market Report:

https://thebusinessresearchcompany.com/report/transfection-technologies-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Transfection Technologies Market Regional Outlook: Where Is Opportunity Concentrated?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Transfection Technologies Market Size Forecast: How Large Could The Market Become By 2030?

The market for transfection technologies has experienced robust expansion in recent years, with projections indicating an increase from $1.31 billion in 2025 to $1.42 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.8%. This historical growth has been driven by factors such as the advancement of molecular biology research, progress in gene expression studies, rising demands for protein production, increased financial support for genomics research, and its early adoption within academic laboratories.

The transfection technologies market is anticipated to experience robust expansion over the coming years. By 2030, it is projected to reach $1.99 billion, driven by a compound annual growth rate (CAGR) of 8.7%. This forecast period growth can be linked to the rise of cell and gene therapies, an expanding pipeline for RNA therapeutics, increased funding in life sciences research, a growing need for effective transfection reagents, and the widening scope of personalized medicine. Key trends shaping this period include a heightened demand for gene editing research instruments, progress in RNA-based therapeutic development, broader application in cell and gene therapy, expansion of academic and biomedical studies, and improvements in non-viral transfection approaches.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Transfection Technologies Market Demand Drivers: What Is Fueling Industry Growth?

The continued expansion of gene therapy is anticipated to drive the transfection technologies market forward. This medical approach works by modifying genetic material—through the introduction, correction, or replacement of defective genes—to treat or prevent illnesses. Growth in this field is fueled by breakthroughs in genetic research, improved vectors and delivery systems, and the potential to address disorders once deemed untreatable. For gene therapy to succeed, transfection technologies play a vital role by enabling the accurate, secure, and efficient transfer of genetic material into target cells. These tools enable both transient and stable genetic alterations, which are critical in the treatment of hereditary conditions and malignancies. As an illustration, in December 2024 the American Society of Gene & Cell Therapy (ASGCT)—a US-based nonprofit medical and scientific body—reported that the FDA authorized six gene therapy products in 2023, compared with five in 2022. Consequently, the upsurge in gene therapy is fueling the expansion of the transfection technologies market.

Transfection Technologies Market Segment Analysis And Revenue Opportunities

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Transfection Technologies Market Innovation Trends: Which Developments Are Transforming The Industry?

Leading players in the transfection technologies market are concentrating on creating cutting-edge innovations, specifically mechanoporation transfection systems, to support increasingly complex and tailored applications in both research and therapeutic fields. Through the application of mechanical forces, mechanoporation transfection systems generate temporary openings in cell membranes, facilitating the entry of genetic material. This technique is both effective and gentle, ensuring improved cell viability. A notable example is from July 2024, when STEMCELL Technologies, a biotechnology firm headquartered in Canada, introduced CellPore, a novel transfection system. This system comprises a benchtop device and the CellPore Transfection Kit 300, which includes a specialized reagent kit along with disposable delivery cartridges. By utilizing controlled, rapid deformation within microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, resulting in minimal cellular disruption and high survival rates. Such attributes are essential for progressing research and the creation of groundbreaking cell and gene therapies.

Transfection Technologies Market Leading Players Shaping Industry Direction

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Access The Complete Transfection Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Transfection Technologies Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Transfection Technologies Market Through 2030?

The transfection technologies market size has shown significant expansion in recent years. This market is anticipated to rise from $1.31 billion in 2025 to $1.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. The historical growth in this sector was primarily due to increased molecular biology research, advancements in gene expression studies, an escalating need for protein production, enhanced funding for genomics research, and its initial integration into academic laboratories.

The market for transfection technologies is anticipated to experience robust expansion over the coming years. This market is projected to reach $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. Key factors contributing to this expansion during the projected timeframe include the proliferation of cell and gene therapies, the expanding pipelines for RNA therapeutics, an increase in investment within life sciences research, the requirement for effective transfection reagents, and the broader application of personalized medicine. Significant trends expected during this period encompass a growing need for gene editing research instruments, the broadened development of RNA-based therapeutics, enhanced utilization in cell and gene therapy applications, an increase in academic and biomedical research activities, and improvements in non-viral transfection techniques.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Significant Factors Are Encouraging Growth In The Transfection Technologies Market?

The increasing adoption of gene therapy is anticipated to fuel the expansion of the transfection technologies market in the future. This therapeutic approach targets the treatment or prevention of illnesses through genetic modification, encompassing the insertion, correction, or substitution of defective genes. The growth of gene therapy stems from advancements in genetic research, improved delivery mechanisms, and its efficacy in addressing genetic conditions that were previously untreatable. Transfection technologies play a vital role in gene therapy by enabling the accurate, secure, and efficient introduction of genetic material into cellular structures. These technologies enable both transient and lasting alterations to the genome, which are fundamental for managing genetic disorders and various cancers. An example illustrating this is from December 2024, where the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) authorized six gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expanding landscape of gene therapy is a significant catalyst for the growth of the transfection technologies market.

How Is The Transfection Technologies Market Structured Across Different Market Segments?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

What Trends Are Shaping The Transfection Technologies Market Structure?

Key companies within the transfection technologies market are prioritizing the development of advanced technology, such as mechanoporation transfection systems, to enable more intricate and customized applications in both research and therapeutics. Mechanoporation transfection systems function by using mechanical forces to create temporary openings in cell membranes, allowing genetic material to enter cells. This method proves efficient and minimally invasive, leading to better preservation of cell viability. For example, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system consists of a benchtop unit and the CellPore Transfection Kit 300, which includes a specialized reagent kit and single-use delivery cartridges. Employing controlled, rapid deformation in microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cellular disruption and high viability. These characteristics are essential for progressing research and the advancement of cutting-edge cell and gene therapies.

Who Are The Key Market Participants In The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Access The Complete Transfection Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Stands As The Largest Contributor To The Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Transfection Technologies Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Transfection Technologies Market During 2026–2030?

The transfection technologies market has witnessed significant growth in its size over recent years. It is projected to expand from $1.31 billion in 2025 to $1.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. This historical growth can be attributed to the rise in molecular biology research, advancements in gene expression studies, the increasing needs for protein production, augmented funding for genomics research, and its initial adoption within academic laboratories.

The transfection technologies market is projected to experience robust expansion over the coming years. Its valuation is set to reach $1.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast timeframe is primarily driven by factors such as the proliferation of cell and gene therapies, the expanding pipelines for RNA therapeutics, an uptick in life sciences research investment, the demand for efficient transfection reagents, and the broadening scope of personalized medicine. Key trends anticipated for this period encompass a rising demand for gene editing research tools, the expansion of RNA-based therapeutics development, increasing use in cell and gene therapy, growth in academic and biomedical research, and the advancement in non-viral transfection methods.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Key Drivers Are Affecting The Transfection Technologies Market Development?

The increasing adoption of gene therapy is anticipated to fuel expansion within the transfection technologies market in the future. Gene therapy involves a method designed to address or avert illnesses through genetic modification, encompassing the introduction, correction, or substitution of defective genes. The growth of gene therapy stems from advancements in genetic research, improved delivery techniques, and its capacity to manage genetic ailments that were once untreatable. Transfection technologies play a vital role in gene therapy, enabling the accurate, secure, and efficient transfer of genetic substances into cells. These technologies facilitate both transient and lasting alterations to the genome, which are indispensable for addressing genetic diseases and cancers. As an illustration, in December 2024, data from the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) cleared six gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the expansion of gene therapy is propelling the development of the transfection technologies market.

Which Segment Categories Are Included In The Transfection Technologies Market Segment Analysis?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Which Trends Are Shaping The Transfection Technologies Market?

Leading firms within the transfection technologies sector are concentrating on creating sophisticated technology, such as mechanoporation transfection systems, to facilitate more intricate and customized uses in research and therapeutic contexts. These mechanoporation systems utilize mechanical forces to form transient openings in cell membranes, which permits genetic material to penetrate cells. This approach is both effective and causes minimal disruption, thereby maintaining superior cell viability. As an illustration, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, introduced CellPore, an inventive transfection system. The system comprises a benchtop device and the CellPore Transfection Kit 300, supplied with a specialized reagent set and disposable delivery cartridges. By employing controlled, swift deformation within microfluidic channels, CellPore proficiently delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, guaranteeing low cell disturbance and robust viability. Such characteristics are vital for progressing research and the advancement of state-of-the-art cell and gene therapies.

Who Are The Active Companies Shaping The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Get The Full Transfection Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Where Is The Transfection Technologies Market Primarily Concentrated By Region?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Transfection Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Transfection Technologies Market During 2026–2030?

The market for transfection technologies has demonstrated robust growth in recent years. It is projected to expand from $1.31 billion in 2025 to $1.42 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion can be ascribed to several factors, including the increasing scope of molecular biology research, advancements in gene expression investigations, a rise in protein production demands, enhanced financial support for genomics research, and its initial integration within academic laboratories.

The transfection technologies market size is anticipated to experience substantial growth in the approaching years. It is projected to expand to $1.99 billion by 2030, demonstrating an 8.7% compound annual growth rate (CAGR). The expansion observed during the forecast period can be attributed to several factors including the rise of cell and gene therapies, the increasing pipelines for RNA therapeutics, growing investment within life sciences research, the demand for efficient transfection reagents, and the broadening reach of personalized medicine. Significant trends expected in the forecast period encompass a rising need for gene editing research tools, the increased development of RNA-based therapeutics, more widespread application in cell and gene therapy, advancements in academic and biomedical research, and progress in non-viral transfection methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Major Factors Are Driving The Expansion Of The Transfection Technologies Market?

The expansion of gene therapy is anticipated to boost the growth of the transfection technologies market in the future. Gene therapy involves a method focused on treating or preventing illnesses through genetic modification, encompassing the insertion, repair, or substitution of defective genes. The increased prevalence of gene therapy stems from advancements in genetic research, improved delivery techniques, and its capacity to address genetic conditions that were formerly untreatable. Transfection technologies play a vital role in gene therapy by enabling the accurate, secure, and efficient introduction of genetic material into cells. These technologies enable both temporary and lasting alterations to the genome, which are fundamental for addressing genetic diseases and various cancers. An example of this trend is that in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) sanctioned six gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the expanding field of gene therapy is a key driver for the growth of the transfection technologies market.

How Are The Various Segments Of The Transfection Technologies Market Categorized?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

What Trends Are Affecting The Expansion Of The Transfection Technologies Market?

Leading firms within the transfection technologies market are concentrating on creating sophisticated technologies, like mechanoporation transfection systems, to support more intricate and customized uses in both scientific investigation and medical treatments. These mechanoporation systems utilize mechanical forces to form transient openings in cell membranes, thereby facilitating the entry of genetic material into cells. This approach is both efficient and causes minimal invasion, which helps maintain superior cell viability. As an illustration, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, introduced CellPore, a novel transfection system. The CellPore system comprises a benchtop device and the CellPore Transfection Kit 300, which is supplied with a specialized reagent kit and disposable delivery cartridges. Employing controlled, swift deformation within microfluidic channels, CellPore proficiently delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, guaranteeing minimal cellular disturbance and robust viability. Such attributes are crucial for advancing scientific research and fostering the creation of advanced cell and gene therapies.

Which Major Firms Influence Developments In The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Read the full transfection technologies market report here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Currently Holds The Largest Share Of The Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Transfection Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the transfection technologies market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Transfection Technologies Market’s size between 2026 and 2030?

The transfection technologies market has experienced robust growth in recent years. It is anticipated to increase from $1.31 billion in 2025 to $1.42 billion in 2026, at a compound annual growth rate (CAGR) of 8.8%. This historical expansion is attributable to several factors, including the rising interest in molecular biology research, significant developments in gene expression studies, the growing demand for protein production, enhanced financial support for genomics research, and its initial integration into academic laboratories.

The transfection technologies market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $1.99 billion, exhibiting a compound annual growth rate (CAGR) of 8.7%. This projected growth is driven by factors such as the expansion of cell and gene therapies, the increasing number of RNA therapeutics in development, greater investment in life sciences research, the need for effective transfection reagents, and the broader application of personalized medicine. Key trends expected during this period encompass a growing need for gene editing research instruments, the widespread development of RNA-based therapeutics, more extensive adoption in cell and gene therapy, an increase in academic and biomedical research activities, and ongoing progress in non-viral transfection techniques.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Drivers Are Shaping Strategic Decisions In The Transfection Technologies Market?

The increasing adoption of gene therapy is anticipated to boost the expansion of the transfection technologies market in the future. Gene therapy represents a method focused on addressing or preventing illnesses through genetic alterations, encompassing the insertion, correction, or substitution of defective genes. The growing prominence of gene therapy stems from advancements in genetic research, improved delivery techniques, and its capability to manage genetic conditions that were formerly untreatable. Transfection technologies play a vital role in gene therapy by enabling the accurate, secure, and efficient introduction of genetic material into cellular structures. These technologies enable both transient and lasting alterations to the genome, which are fundamental for addressing genetic disorders and various cancers. As an illustration, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) sanctioned six gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expansion of gene therapy is propelling the growth of the transfection technologies market.

What Segment Categories Are Covered In The Transfection Technologies Market?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are New Market Trends Shaping The Landscape Of The Transfection Technologies Market?

Leading companies in the transfection technologies market are prioritizing the development of advanced systems, such as mechanoporation transfection systems, to enable more intricate and personalized applications in both research and therapeutics. These mechanoporation systems function by utilizing mechanical forces to create temporary openings in cell membranes, allowing genetic material to enter the cells. This method demonstrates efficiency and minimal invasiveness, contributing to better preservation of cell viability. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology firm, unveiled CellPore, an innovative transfection system. This system comprises a benchtop unit and the CellPore Transfection Kit 300, which includes a specialized reagent kit and single-use delivery cartridges. By employing controlled, rapid deformation within microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, ensuring minimal cell disruption and high viability. These attributes are crucial for advancing research and the progression of cutting-edge cell and gene therapies.

Which Major Firms Are Strengthening Their Position In The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Transfection Technologies Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical contract development and manufacturing organization (cmo) market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market By The End Of 2029?

The transfection technologies market has shown strong growth in recent years. It is anticipated to expand from $1.21 billion in 2024 to $1.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.3%. This historic growth is largely attributable to the increasing prevalence of chronic diseases, the expanded applications of transfection technologies, the growing demand for cell & gene therapy, increasing R&D investments, and rising cancer incidences.

The transfection technologies market is projected to experience substantial expansion over the coming years, reaching $1.83 billion by 2029, with an anticipated compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period is primarily driven by factors such as the increasing prevalence of chronic and immunological conditions, the escalating demand for cell-based therapies, a surge in protein production requirements, heightened investments and financial backing for developing drug delivery systems, and the growing need for monoclonal antibodies. Key trends anticipated in this period encompass heightened research and development efforts in cell-based therapies, the integration of technologically sophisticated transfection methods, an escalating requirement for advanced therapeutic delivery solutions, increased utilization of dual-reporter assays and co-transfection experiments, and an intensifying emphasis on personalized medicine.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Business Drivers Are Underpinning The Growth Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

The increasing adoption of gene therapy is anticipated to fuel the expansion of the transfection technologies market in the future. Gene therapy represents an approach designed to address or avert illnesses through gene manipulation, specifically involving the introduction, mending, or substitution of defective genes. The ascent of gene therapy is fueled by advancements in genetic research, improved delivery techniques, and its capacity to address genetic disorders that were previously untreatable. Transfection technologies play a vital role in gene therapy, enabling the accurate, secure, and efficient transfer of genetic material into cellular structures. These technologies enable both transient and lasting alterations to the genome, which are fundamental for managing genetic ailments and malignancies. As an illustration, in July 2023, a report from the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, indicated that by the close of the first quarter (Q1) of 2023, 247 gene therapies were in Phase II. This figure saw a 5% increase, reaching 260 by the end of the second quarter (Q2). Consequently, the expanding use of gene therapy is propelling the expansion of the transfection technologies market.

What Are The Principal Segment Types In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are Industry Trends Steering The Expansion Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?

Leading companies within the transfection technologies market are prioritizing the development of advanced solutions, such as mechanoporation transfection systems, to enable more intricate and tailored applications in both research and therapeutic contexts. Mechanoporation transfection systems function by employing mechanical forces to create transient pores in cell membranes, thereby allowing genetic material to enter cells. This approach is highly efficient and minimally invasive, leading to improved cell viability. As an illustration, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched CellPore, an innovative transfection system. This system consists of a benchtop unit and the CellPore Transfection Kit 300, which comes with a specialized reagent kit and single-use delivery cartridges. Leveraging controlled, rapid deformation within microfluidic channels, CellPore effectively introduces small molecules, nucleic acids, proteins, and gene editing complexes into cells, while ensuring minimal cellular disruption and high viability. These characteristics are crucial for advancing research and fostering the creation of cutting-edge cell and gene therapies.

Which Companies Are Contributing Significantly To The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Growth?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Offers The Most Opportunity For Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Expansion?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2025, By The Business Research Company

Transfection Reagents And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

5G Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/5g-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Projected Valuation Of The Transfection Technologies Market In The Coming Years?

In recent years, the market size of transfection technologies has experienced significant growth. It is predicted to increase from $1.21 billion in 2024 to $1.31 billion in 2025, marking a compound annual growth rate (CAGR) of 8.3%. The past growth in this sector is largely due to the rising occurrence of chronic diseases, the broadening utilization of transfection technologies, the escalating demand for cell and gene therapy, higher investments in research and development, and the increasing rates of cancer incidents.

In the ensuing years, a robust expansion is anticipated in the transfection technologies market, with projections reaching $1.83 billion by 2029 at a CAGR of 8.8%. This predicted growth within the forecasted period can be ascribed to a variety of factors. Included amongst these are an escalating prevalence of chronic and immunological diseases, the growing necessity for therapies based on cell manipulation, an increase in protein production demand, a surge in investments and funding for drug delivery system development, plus a heightened demand for monoclonal antibodies. The forecast period is also expected to witness major trends such as a surge in research and development focused on cell-based therapies, the acceptance of cutting-edge methods in transfection, rising demand for advanced therapeutic delivery systems, an increased application of dual-reporter assays and co-transfection experiments along with a growing emphasis on personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

What Are The Primary Factors Supporting The Transfection Technologies Market Expansion?

The growth of the transfection technologies market is anticipated to be fueled by the in gene therapy. Gene therapy is an approach that seeks to prevent or treat diseases by altering genes, which involves the insertion, repair, or replacement of defective genes. The increased trajectory of gene therapy is influenced by advancements in genetic research, improved delivery techniques, and its capacity to manage previously untreatable genetic conditions. Transfection technologies have a pivotal role in gene therapy as they enable the accurate, safe, and efficient transport of genetic material into cells. These technologies help with both temporary and permanent modifications of the genome, which are critical for the treatment of genetic disorders and cancers. As an illustration, the American Society of Gene & Cell Therapy (ASGCT) and Citeline, both US-based entities, reported in July 2023 that there were 247 gene therapies in Phase II at the end of the first quarter (Q1) of 2023. This figure rose by 5%, reaching 260 by the close of the second quarter (Q2). As such, the growth of the transfection technologies market is being spurred on by the increase in gene therapy.

What Is The Segment Breakdown Of The Transfection Technologies Market?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are Global Trends Impacting The Development Of The Transfection Technologies Market?

Key players in the transfection technologies industry are concentrating their efforts on creating innovative technology like mechanoporation transfection systems. These systems are designed to support intricate and bespoke applications in research and treatment fields. The technique behind mechanoporation transfection systems involves using mechanical force to open temporary pores in cell membranes, providing a passageway for genetic material into cells. This technique is more efficient and less invasive, maintaining higher cell survival rates. For example, in July 2024, STEMCELL Technologies, a Canadian biotech firm, introduced CellPore, a groundbreaking transfection system. The system comprises of a benchtop device along with the CellPore Transfection Kit 300, equipped with a unique reagent kit and one-time use delivery cartridges. CellPore uses a controlled, rapid deformation process in microfluidic channels to effectively insert small molecules, nucleic acids, proteins, and gene editing complexes into cells. This ensures minimal cell disruption and high cell viability. Such attributes are vital in pushing research boundaries and creating new cell and gene therapies.

Which Companies Are Contributing Significantly To The Transfection Technologies Market Growth?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Is Leading Innovation In The Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Through 2029?

The market size of transfection technologies has seen significant growth in the previous years. The market’s value is projected to increase from $1.21 billion in 2024 to $1.31 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 8.3%. This growth during the historical period is due to factors such as increased occurrence of chronic diseases, broadened use of transfection technologies, heightened demand for cell & gene therapy, an increase in R&D investments, and a surge in cancer cases.

In the coming years, the market size for transfection technologies is predicted to experience robust growth, soaring to “$1.83 billion by 2029 with a yearly average growth rate of 8.8%. This growth during the forecasted period could be due to the surge in chronic and immunological diseases, an increased necessity for cell-centered treatments, growing demand for protein manufacturing, escalating investments and resources funneled towards the creation of drug delivery systems, and a rise in the need for monoclonal antibodies. The projection period also sees a rising trend in research and development in cell-oriented treatments, embracing advanced methods in transfection, a rise in the demand for advanced therapeutic delivery systems, an increased practice of dual-reporter assays and co-transfection studies, and an intensified emphasis on personalized medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

What Market Forces Are Driving The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Sector In 2025 And Beyond?

The expansion of the pharmaceutical contract development and manufacturing market is fueled by the rising global demand for medications. The broad prevalence of diseases and the desire for a longer lifespan has heightened the requirement for medications, compelling pharmaceutical manufacturers to boost the production of existing drugs and escalate investment in research and development for new drug exploration. This compels these firms to partner with contract manufacturing organizations (CMOs), as a strategy to reduce operational expenditures, subsequently increasing the need for pharmaceutical contract development and manufacturing market. Based on information from Alkermes PLC., a biopharmaceutical firm, pharmaceutical contract manufacturing is likely to become a strategic choice for a variety of companies, from large-scale to smaller niche pharmaceutical entities, principally due to pharmaceutical companies’ pursuit of cost reduction.

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are Key Trends Driving Expansion In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Industry?

Leading transfection technologies market players are directing their efforts towards the creation of sophisticated technology like mechanoporation transfection systems. These systems facilitate highly complex and tailored applications within research and therapeutic fields. The unique process of mechanoporation transfection involves mechanical forces opening temporary pores in cellular membranes to enable entry of genetic elements. This method allows for greater efficiency and less invasiveness, thus ensuring cell vitality. A case in point, STEMCELL Technologies, a biotech firm from Canada, unveiled its revolutionary transfection system, CellPore, in July 2024. This system constitutes a benchtop unit and a CellPore Transfection Kit 300. It’s equipped with a specific reagent set and one-time use delivery cartridges. By triggering controlled, quick deformation in microfluidic channels, CellPore can effectively transport small molecules, nucleic acids, proteins, and gene editing structures into cells. It ensures low cellular disruption and high survival, characteristics key for propelling research and innovating cell and gene therapies.

Which Firms Are Considered Leaders In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Space?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

What Role Do Regional Policies And Investments Play In Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Expansion?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Transfection Technologies Market, and What Factors Will Drive It?

In recent times, there has been substantial growth in the market size of transfection technologies. A rise from $1.21 billion in 2024 to $1.31 billion in 2025 is forecasted, showcasing a compound annual growth rate (CAGR) of 8.3%. The historical growth of this market is a reflection of the rising cases of chronic illnesses, the extended use of transfection technologies, the escalating demand for cell and gene therapy, increased investments in research and development, and a surge in cancer cases.

In the coming years, the transfection technologies market is poised for significant growth, expected to reach a value of $1.83 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.8%. The predicted growth in this timeframe is thanks to a number of factors: increasing rates of chronic and immunological diseases, an escalating need for cell-based treatments, a rise in the demand for protein production, expanding investments and funding dedicated to crafting drug delivery systems, and a surge in the demand for monoclonal antibodies. Key trends during this forecasted period involve increased R&D in cell-based therapy, the adoption of cutting-edge transfection methods, growing demand for innovative therapeutic delivery systems, escalating usage of dual-reporter assays and co-transfection experiments, and an intensified emphasis on personalized medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTransfection Technologies Market?

The surge in gene therapy is anticipated to act as a catalyst for the expansion of the transfection technologies market. It is a therapeutic method with a goal to cure or avert diseases by gene alterations which encompass insertion, repair, or replacement of defective genes. The boom in gene therapy is accelerated by advancements in genetic studies, improved delivery techniques, and its capacity to cure genetic disorders which were previously untreatable. Transfection technologies play a crucial role in gene therapy, enabling accurate, secure, and effective conveyance of genetic matter into cells. These technologies aid both temporary and permanent changes in the genome, which is vital for the treatment of genetic disorders and cancers. For example, in July 2023, as per the report revealed by the American Society of Gene & Cell Therapy (ASGCT), a professional organization based in the US, and Citeline, a drugs and appliances provider also based in the US, there were 247 gene therapies in Phase II at the end of quarter one (Q1) of 2023. This figure rose by 5 percent, touching 260 by the completion of quarter two (Q2). Hence, the surge in gene therapy is fuelling the expansion of the transfection technologies market.

Which Segments in the Transfection Technologies Offer the Most Growth?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theTransfection Technologies Market?# Market?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Transfection Technologies Industry?

Leading organizations in the transfection technologies market are concentrating on the progression of high-tech systems, such as mechanoporation transfection methodologies, to promote intricate and personalized operations in research and therapeutic applications. Mechanoporation transfection strategies use mechanical effects to produce temporary holes in cell membranes, enabling genes to infiltrate cells. This approach is proficient and minimally intrusive, sustaining superior cell survival rates. For instance, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, unveiled CellPore, an inventive transfection system. The system comprises of a benchtop unit and the CellPore Transfection Kit 300, equipped with a specialized reagent bundle and one-time use delivery cartridges. By utilizing controlled, quick deformation in microfluidic channels, CellPore effectively delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, guaranteeing minimal cell disruption and improved survival rates. These elements are crucial for propelling research and introducing revolutionary cell and gene therapies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

What Are the Key Elements That Define the Transfection Technologies Market?

Transfection technologies are the intentional introduction of nucleic acids into cells using chemical, physical, or biological methods to modify gene expression or genetic content. It is used to study gene function, produce proteins, silence genes via ribonucleic acid(RNA) interference (siRNA/miRNA), and potentially treat genetic diseases by introducing functional genes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19228

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model